News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, February 18, 2019

ORA asks that when drafting a proposal to NIH please include the full name of all personnel

listed on your proposal.  We are required by NIH to verify that individuals are not listed on the exclusion

list provided by the federal government.  Sometimes names are very similar and we need the complete

names to verify correctly.

 

 

Oklahoma Center for Respiratory and Infectious Diseases – Centers of Biomedical Research

Excellence (CoBRE) Call for Proposals – Deadline April 15, 2019 – For additional information see the

attached document.

OK-State CoBRE

 

Due to the recent lapse in appropriations, implementation of the revised NSF Proposal and Award

Policies and Procedures Guide (PAPPG), (NSF 19-1) was postponed. We are pleased to

announce that the revised PAPPG will now be effective for proposals submitted, or due, on or after

February 25, 2019.  

You are encouraged to review the by-chapter summary of changes provided in the Introduction section

of the PAPPG.  To learn about the changes in the revised PAPPG (NSF 19-1), please view the latest

NSF Proposal and Award Policy Update webinar.

While this version of the PAPPG becomes effective on February 25, 2019, in the interim, the guidelines

contained in the current PAPPG (NSF 18-1) continue to apply.  We will ensure that the current version

of the PAPPG remains on the NSF website, with a notation to proposers that specifies when the new

PAPPG (including a link to the new Guide) will become effective.

Associated award terms and conditions (including RTC NSF Agency Specific Requirements, GC-1 and

FL-26) will also be effective for proposals submitted or due, on or after, February 25, 2019. Cooperative

Agreement Conditions (CA-FATC) and CA-FATC Modifications and Supplemental terms and conditions

are effective for new awards and funding actions to existing awards beginning on February 12, 2019.

If you have any questions regarding these changes, please contact the DIAS/Policy Office at policy@nsf.gov.

https://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf19001

 

 

Note 2-Step Submission Process for RPPRs with Inclusion Enrollment Data

With the launch of the new Human Subjects System (HSS), there is now a new two-step submission

process for any Research Performance Progress Reports (RPPR) reporting inclusion enrollment updates:

  1. Submission of the inclusion data via HSS, followed by…
  2. A separate submission for the full RPPR via eRA Commons

For additional details and instructions for signing officials and principal investigators, see the eRA

Information page: https://era.nih.gov/node/522

 

 

The Office of Technology Development will offer the Innovation to Impact Series Session 6 

“Understanding SBIT/STTR Opportunities.” Tom Wavering will be the presenter.

This session will occur on February 27th from Noon- 1:00 pm in Biomedical Research Center Building,

Room 103. Lunch will be provided.

Please RSVP to rashaffer@ou.edu by February 22nd. Space is limited to the first 15 attendees.

 

 

The Oklahoma Center of Biomedical Research Excellence in Structural Biology (OCSB)

invites proposals for pilot project grants to be funded through our NIH/NIGMS COBRE award

(due March 29, 2019).  The OCSB seeks to promote and support research that combines structural

biology approaches (defined broadly) with other functional characterization of important biomolecules

relevant to the NIH mission of improving human health. The OCSB anticipates funding 4-5 applications

at up to $50,000/year (direct costs) plus institutional F&A costs for projects external to OU-Norman for

up to 2 years of funding.”

 

 

3rd Annual OU-OUHSC Biomedical Engineering Symposium – Friday, March 29, 2019.

Call for Abstracts Deadline is Tuesday, February 7, 2019.  For additional information see the attached

document or go to http://bit.ly/ou_symposium2019

Symposium

 

Presbyterian Health Foundation (PHF)for specific programs and deadlines go to:

https://research.ouhsc.edu/News/presbyterian-health-foundation-grants-2019-request-for-applications

 

 

COMAA DEADLINE – Deadline April 1, 2019.  For additional information please see the attachment.

COMAA

 

Oklahoma Center for the Advancement of Science and Technology (OCAST)

Deadline of March 1, 2019       

Health Research Program (HR)

            Health Research Postdoctoral Fellowship Program (HF)

            Oklahoma Applied Research Support Program (AR)

Faculty and Student Intern Partnership (IP)

https://www.ok.gov/ocast/FUNDING_OPPORTUNITIES/index.html

 

 

Grants and Contracts Accounting – Cost Transfers Class – Thursday, April 18, 2019 at

2:00PM.  Please go to the OUHSC HR Training Site for more complete information and to sign up.

 

 

OK-INBRE Research Project Investigator (RPI) Program

Proposal deadline: February 22, 2019

Call for proposals:

https://okinbre.ouhsc.edu/Funding-Opportunities/Funding-Opportunities-for-OUHSC-and-OMRF

The Oklahoma IDeA Network of Biomedical Research Excellence (OK-INBRE) is requesting applications

for Research Project Investigator Awards (RPI).  The program seeks to support proposals designed to

generate preliminary data that enhances the competitiveness of the OUHSC/OMRF investigators for

future extramural funding.  The proposed project must align with one of the biomedical research themes

of the OK-INBRE program: Cancer, Developmental Biology or Infectious Diseases.  The RPI project

period is 2 ½ years in duration funded at $100,000 in direct costs per year.  Selected projects will

commence in May 2019.

 

 

ORAU-Directed Research and Development (ODRD) Program

The FY 2019 competition for collaborative awards of up to $75,000 to be shared between the university

and ORAU researchers is now open. We anticipate and expect that these seed funds will position the

collaborative teams to be more competitive for new, external funding opportunities. The deadline for joint

ORAU/university proposals is March 25, 2019 and potential university partners are encouraged to

submit concepts for discussion with ORAU partners as soon as possible. 

https://www.orau.org/university-partnerships/member-grant-programs/odrd.html

 

 

NIH NOTICES

 

Notice of Availability of Competitive Supplements/Revisions for the INCLUDE (Investigation of

Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Competitive

Supplement/Revision Clinical Trial Optional) (NOT-OD-19-071)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-071.html

 

Updates to NIH Policy on ESI Application Status (NOT-OD-19-072)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-072.html

 

Notice of Participation of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in PAR-19-147

"Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)" (NOT-AA-19-007)
https://grants.nih.gov/grants/guide/notice-files/NOT-AA-19-007.html

 

Notice of Participation of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in PAR-19-146

"Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed)" (NOT-AA-19-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-AA-19-008.html

 

Notice of Special Interest in Supporting Administrative Supplements for Fetal Alcohol Spectrum Disorders

(FASD) (NOT-AA-19-009)
https://grants.nih.gov/grants/guide/notice-files/NOT-AA-19-009.html

 

Notice of NIA's Participation in RFA-OD-19-001 "Botanical Dietary Supplements Research Centers

(BDSRC) (U19 Clinical Trial Optional)" (NOT-AG-19-006)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-19-006.html

 

Request for Information (RFI): Immunologic Assays for Identifying Correlates of Protection (COP)

Against Congenital Cytomegalovirus Transmission and/or Disease (NOT-AI-19-035)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-19-035.html

 

Notice of Special Interest: Administrative Supplements for Characterization and Further Development

of Humanized Immune System (HIS) Mice (NOT-AI-19-040)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-19-040.html

 

Notice of Expiration of Funding Opportunity Announcements PAR-19-168 and PAR-19-169

"Biology of Bladder Cancer (R01, R21 Clinical Trial Optional)" (NOT-CA-19-022)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-19-022.html

 

Notice: NIDA Accepting Competitive Revision Applications to Establish an Addiction Medicine

Practice Based Research Network to Address the National Opioid Crisis (NOT-DA-19-022)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-19-022.html

 

Notice of Change to Council Dates for PAR-19-143 "NIDCD Research Career Enhancement Award

for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required)"

(NOT-DC-19-006)
https://grants.nih.gov/grants/guide/notice-files/NOT-DC-19-006.html

 

Updates to Section I & II for PAR-15-187 - Enhancing Regulatory Science for the Risk Based

Assessment of Emerging Manufacturing Technologies (NOT-FD-19-004)
https://grants.nih.gov/grants/guide/notice-files/NOT-FD-19-004.html

 

Notice of Change to Funds Available and Award Budget for PAR-16-099 "NARMS Cooperative

Agreement Program to Enhance and Strengthen Antibiotic Resistance Surveillance in Retail Food

Specimens (U01)" (NOT-FD-19-005)
https://grants.nih.gov/grants/guide/notice-files/NOT-FD-19-005.html

 

Notice of Joint SBE/NIGMS Initiative to Support a Science of Science Policy Approach to Analyzing

and Innovating the Biomedical Research Enterprise (SCISIPBIO) (NOT-GM-19-011)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-19-011.html

 

Request for Information (RFI): Input on In-depth Stem Cell Characterization (NOT-HL-19-679)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-19-679.html

 

Notice of NIMHD Participation in PA-19-029 "Innovation Corps (I-Corps) at NIH Program for NIH

and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)" (NOT-MD-19-020)
https://grants.nih.gov/grants/guide/notice-files/NOT-MD-19-020.html

 

Notice to Extend PAR-19-027, "Basic Neurodevelopmental Biology of Circuits and Behavior

(R01 Clinical Trial Not Allowed)" (NOT-MH-18-071)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-071.html

 

Notice to Extend, PAR-19-028 "Basic Neurodevelopmental Biology of Brian Circuits and Behavior

(R21 Clinical Trial Not Allowed) (NOT-MH-18-072)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-072.html

 

Notice of Correction for RFA-MH-18-700 "Clinical Trials to Test the Effectiveness of Treatment,

Preventive and Services Interventions (Collaborative R01 Clinical Trial Required)" (NOT-MH-19-014)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-014.html

 

Notice of Correction for RFA-MH-18-701 "Clinical Trials to Test the Effectiveness of Treatment,

Preventive and Services Interventions (R01 Clinical Trial Required)" (NOT-MH-19-015)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-015.html

 

Notice of Correction for RFA-MH-18-702 "Early Stage Testing of Pharmacologic or Device-Based

Interventions for the Treatment of Mental Disorders (R61/R33- Clinical Trial Required)"

(NOT-MH-19-016)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-016.html

 

Notice of Correction for RFA-MH-18-704 "Development of Psychosocial Therapeutic and Preventive

Interventions for Mental Disorders (R61/R33- Clinical Trial Required)" (NOT-MH-19-017)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-017.html

 

Notice of Correction for RFA-MH-18-705, "Development of Psychosocial Therapeutic and Preventive

Interventions for Mental Disorders (R33 Clinical Trial Required)" (NOT-MH-19-018)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-018.html

 

Notice of Correction for RFA-MH-18-706, "Pilot Effectiveness Trials for Treatment, Preventive and

Services Interventions (R34- Clinical Trial Required)" (NOT-MH-19-019)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-019.html

 

Notice of Correction for RFA-MH-18-707, "Confirmatory Efficacy Clinical Trials of Non-Pharmacological

Interventions for Mental Disorders (R01 Clinical Trial Required)" (NOT-MH-19-020)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-020.html

 

Notice of Removal of Matching Requirement Instructions for RFA-NS-19-016 "HEAL Initiative:

Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)" (NOT-NS-19-030)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-030.html

 

Notice of Removal of Matching Requirement Instructions for RFA-NS-19-017 "HEAL Initiative:

Translational Devices to Treat Pain (U44 Clinical Trial Optional)" (NOT-NS-19-031)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-031.html

 

Notice of Removal of Matching Requirement Instructions for RFA-NS-19-018 "HEAL Initiative:

Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)" (NOT-NS-19-032)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-032.html

 

Notice of Correction to Cooperative Agreement Terms and Conditions of Award for RFA-NS-19-020

"HEAL Initiative: Optimization of Non-addictive Therapies (Small Molecules and Biologics) to Treat

Pain (U44 - Clinical Trial Not Allowed)" (NOT-NS-19-033)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-033.html

 

Notice of Change to IC and NIH Office of Interest Areas and Specific Requirements for

RFA-NS-19-009 "Promoting Research on Music and Health: Fundamentals and Applications

(R21 Clinical Trial Optional)" (NOT-NS-19-035)

https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-035.html

 

 

Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

 

Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed)

(RFA-AI-19-012) – Deadline May 31, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-012.html

 

Functional RNA Modifications Environment and Disease (FRAMED) (R01 Clinical Trial Not Allowed)

(RFA-ES-19-001) – Deadline May 16, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-19-001.html

 

Functional RNA Modifications Environment and Disease (FRAMED) (R21 Clinical Trial Not Allowed)

(RFA-ES-19-002) – Deadline May 16, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-19-002.html

 

Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not

Allowed) (RFA-ES-19-005) – Deadline April 9, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-19-005.html

 

Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not

Allowed) (RFA-ES-19-006) – Deadline April 9, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-19-006.html

 

Bioequivalence of Topical Products: Bioequivalence Considerations for Ungual, Scalp, Vaginal,

Anal or Rectal Dosage Forms (U01 Clinical Trial Not Allowed) (RFA-FD-19-008)

Deadline April 11, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-19-008.htm

 

 

Bioequivalence of Topical Products: Elucidating the Sensorial and Functional Characteristics of

Compositionally Different Topical Formulations (U01 Clinical Trial Required) (RFA-FD-19-009)

Deadline April 11, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-19-009.html

 

Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug

Products Using Pharmacokinetic Tomography (U01 Clinical Trial Not Allowed) (RFA-FD-19-010)

Deadline April 11, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-19-010.html

 

Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical

Trials (U01- Clinical Trial Required) (RFA-FD-19-014) – Deadline April 4, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-19-014.html

 

Refinement and Testing of Interventions to Sustain ADHD Treatment Effects Across Settings and

Developmental Transitions (R34 Clinical Trial Required) (RFA-MH-20-100) – Deadlines May 1 and

November 15, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-100.html

 

Secondary Data Analysis to Examine Long-Term and/or Potential Cross-Over Effects of Prevention

Interventions: What are the Benefits for Preventing Mental Health Disorders? (R01 Clinical Trial Not

Allowed) (RFA-MH-20-110) – Deadline May 2, 2019 and January 2, 2020
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-110.html

 

Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early

and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54 Clinical Trial Not Allowed)

(RFA-NS-19-022) – Deadline April 10, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-022.html

 

INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE

(INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) (RFA-OD-19-015)

Deadline March 14, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-015.html

 

Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions

across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)

(RFA-OD-19-016) – Deadline March 14, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-016.html

 

Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome:

Phased Awards for INCLUDE (R61/R33 Clinical Trials Required) (RFA-OD-19-018)

Deadline March 14, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-018.html

 

Biology of Bladder Cancer (R01 Clinical Trial Optional) (PAR-19-183) – Deadline June 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-183.html

 

Biology of Bladder Cancer (R21 Clinical Trial Optional) (PAR-19-184) – Deadline June 16, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-184.html

 

 

OTHER DEADLINES

 

Robert Wood Johnson Foundation – Evidence for Action: Investigator-Iniated Research to Build a

Culture of Health – Deadline OPEN
https://www.rwjf.org/en/library/funding-opportunities/2015/evidence-for-action-investigator-initiated-research-to-build-a-culture-of-health.html

 

 

Print

x